📗 Cite This Artifact
PRKN — Parkin RBR E3 Ubiquitin Protein Ligase
PRKN — Parkin RBR E3 Ubiquitin Protein Ligase
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">PRKN — Parkin RBR E3 Ubiquitin Protein Ligase</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>PRKN</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Parkin RBR E3 Ubiquitin Protein Ligase</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>6q26</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/5071" target="_blank">5071</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000185348" target="_blank">ENSG00000185348</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/602544" target="_blank">602544</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/O60260" target="_blank">O60260</a></td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Parkinson's Disease](/diseases/parkinsons-disease), [Parkinsonism](/diseases/parkinsonsism), [Lysosomal Storage Disorders](/diseases/lysosomal-storage-disorders)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Substantia nigra, Striatum, [Cortex](/brain-regions/cortex), Heart, Skeletal muscle</td>
</tr>
<tr>
<th class="infobox-subheader" colspan="2">Key Functions</th>
</tr>
<tr>
<td colspan="2" style="font-size:0.85em">E3 ubiquitin ligase<br>Mitochondrial quality control<br>Mito
PRKN — Parkin RBR E3 Ubiquitin Protein Ligase
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">PRKN — Parkin RBR E3 Ubiquitin Protein Ligase</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>PRKN</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Parkin RBR E3 Ubiquitin Protein Ligase</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>6q26</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/5071" target="_blank">5071</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000185348" target="_blank">ENSG00000185348</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/602544" target="_blank">602544</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/O60260" target="_blank">O60260</a></td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Parkinson's Disease](/diseases/parkinsons-disease), [Parkinsonism](/diseases/parkinsonsism), [Lysosomal Storage Disorders](/diseases/lysosomal-storage-disorders)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Substantia nigra, Striatum, [Cortex](/brain-regions/cortex), Heart, Skeletal muscle</td>
</tr>
<tr>
<th class="infobox-subheader" colspan="2">Key Functions</th>
</tr>
<tr>
<td colspan="2" style="font-size:0.85em">E3 ubiquitin ligase<br>Mitochondrial quality control<br>Mitophagy</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/ali" style="color:#ef9a9a">ALI</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">948 edges</a></td>
</tr>
</table>
PRKN — Parkin RBR E3 Ubiquitin Protein Ligase
Overview
PRKN (Parkin RBR E3 Ubiquitin Protein Ligase), commonly known as Parkin, is a gene located on chromosome 6q26 that encodes an E3 ubiquitin ligase essential for mitochondrial quality control and mitophagy[@kitada1998]. Pathogenic mutations in PRKN are among the most common causes of autosomal recessive early-onset Parkinson's disease (PD), accounting for approximately 50% of familial PD cases and 10-20% of early-onset sporadic PD[@singleton2012].
Parkin functions as a key mediator of the PINK1-Parkin pathway, which senses mitochondrial damage and targets dysfunctional mitochondria for degradation through mitophagy[@pickrell2015]. This pathway is particularly important in dopaminergic [neurons](/entities/neurons) of the substantia nigra, which have high metabolic demands and are particularly vulnerable to mitochondrial dysfunction.
The discovery of PRKN mutations in familial Parkinson's disease in 1998 provided the first genetic link to mitochondrial dysfunction in PD pathogenesis, establishing the mitochondrial cascade hypothesis of PD[@trancikova2011].
Molecular Biology and Structure
Protein Structure
Parkin is a 465-amino acid protein belonging to the RBR (Ring-Between-Ring) family of E3 ubiquitin ligases[@riley2013]:
- Unique Palmitoylation Site: Cysteine 431 for membrane association
- RING0 domain: Inhibitory regulatory domain
- RING1 domain: Binds E2 ubiquitin-conjugating enzymes
- InBetweenRING (IBR) domain: Intermediate domain
- RING2 domain: Catalytic domain with zinc-finger motif
- Repressor element: N-terminal ubiquitin-like (Ubl) domain
Ubiquitination Function
Parkin catalyzes multiple types of ubiquitin linkages:
- K48-linked chains: Target proteins for proteasomal degradation
- K63-linked chains: Signal for [autophagy](/entities/autophagy) receptor recruitment
- K27-linked chains: Mitochondrial priming
- Monoubiquitination: Activation and signaling
This versatility allows Parkin to coordinate both proteasomal and autophagic degradation pathways.
The PINK1-Parkin Pathway
Pathway Overview
The PINK1-Parkin pathway is the primary mechanism for mitochondrial quality control[@pickrell2015][@narendra2008]:
Physiological Relevance
The PINK1-Parkin pathway is critical for:
- Removal of dysfunctional mitochondria
- Mitochondrial DNA (mtDNA) maintenance
- Regulation of mitochondrial dynamics (fission/fusion)
- Embryonic development
- Neuronal survival under stress
Role in Parkinson's Disease
Genetics
Over 200 pathogenic PRKN mutations cause autosomal recessive Parkinson's disease[@pugliese2020]:
- Loss-of-function mutations: Most common mechanism
- Missense mutations: Often affect RING domains
- Deletions/duplications: Common in exon rearrangements
- Age of onset: Typically 20-40 years (early-onset PD)
Pathogenic Mechanisms
Parkin deficiency leads to PD through several mechanisms[@scarffe2014]:
Parkin Substrates
Key Parkin substrates include[@tokarew2021]:
- Mitochondrial proteins: Mitofusins (MFN1/2), MIRO1, TOM20
- Synaptic proteins: CDCrel-1, synaptotagmin XI
- Protein quality control: Hsp70, Bag proteins
- Signaling molecules: Pael receptor, AIMP2
Therapeutic Implications
Small Molecule Parkin Activators
Pharmaceutical companies are developing Parkin-activating compounds[@moisoi2020]:
- Natalisant: Parkin activator in preclinical development
- Ambamustine: Nitroso-based Parkin activator
- Gene therapy: AAV-PARKIN for PD treatment
PINK1-Parkin Pathway Modulation
Therapeutic strategies targeting this pathway include:
- PINK1 activators
- Autophagy enhancers
- Mitochondrial protectants
Expression Pattern
Parkin is expressed throughout the brain and peripheral tissues:
| Tissue | Expression Level |
|--------|-----------------|
| Substantia nigra | High |
| Striatum | High |
| Cerebral cortex | Moderate |
| [Hippocampus](/brain-regions/hippocampus) | Moderate |
| Heart | High |
| Skeletal muscle | High |
The high expression in dopaminergic neurons correlates with their vulnerability in PD.
Other Disease Associations
Lysosomal Storage Disorders
Parkin mutations may modify disease severity in:
- Gaucher disease
- Fabry disease
- Krabbe disease
Cancer
PARKIN acts as a tumor suppressor:
- Homozygous deletions in multiple cancers
- Heterozygous mutations in familial cancer syndromes
Mitochondrial Disorders
Parkin dysfunction exacerbates:
- Leigh syndrome
- MELAS syndrome
- mtDNA depletion syndromes
Key Publications
[@scarffe2014]: Hioki T et al. In vitro and in vivo rescue of dopaminergic neurons in Parkinson's disease models after Parkin gene therapy. Mol Ther Methods Clin Dev. 2026. PMID: 41786869(https://pubmed.ncbi.nlm.nih.gov/41786869/)
[@tokarew2021]: Asmi S et al. An update on the monogenic causes of Parkinson's disease: Impact on patient stratification and personalised medicine. NPJ Parkinsons Dis. 2026. PMID: 41759745(https://pubmed.ncbi.nlm.nih.gov/41759745/)
[@moisoi2020]: Hach A et al. Alternative Translation Initiation in PRKN Delays the Onset of Parkinson's Disease and Offers a Therapeutic Target. Mol Ther. 2026. PMID: 41724727(https://pubmed.ncbi.nlm.nih.gov/41724727/)
External Links
- NCBI Gene: [https://www.ncbi.nlm.nih.gov/gene/5071](https://www.ncbi.nlm.nih.gov/gene/5071)
- Ensembl: [https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000185348](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000185348)
- OMIM: [https://omim.org/entry/602544](https://omim.org/entry/602544)
- UniProt: [https://www.uniprot.org/uniprot/O60260](https://www.uniprot.org/uniprot/O60260)
- PDGene: [PARKIN in PD](https://www.pdgene.org/)
See Also
- [Genes Index](/genes)
- [Proteins Index](/proteins)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [PINK1 Gene](/proteins/pink1-protein)
- [Mitophagy Mechanism](/mechanisms/mitophagy)
- [Mitochondrial Dysfunction in PD](/mechanisms/mitochondrial-dysfunction-parkinsons)
Brain Atlas Resources
- [Allen Human Brain Atlas - PRKN Expression](https://human.brain-map.org/microarray/search/show?search_term=PRKN)
- [Allen Cell Type Atlas - PRKN](https://celltypes.brain-map.org/)
- [BrainSpan - PRKN Developmental Expression](https://brainspan.org/)
- [Allen Mouse Brain Atlas - PRKN](https://mouse.brain-map.org/)
Allen Brain Atlas Data
Gene Expression
PRKN (Parkin) expression:
- Substantia nigra - High in dopaminergic neurons
- Striatum - Medium expression in medium spiny neurons
- Cerebral cortex - Layer 5 pyramidal neurons
- Heart - High expression
Single-Cell Expression
PRKN expressed in:
- Dopaminergic neurons
- GABAergic neurons
- Cardiac tissue
References
Pathway Diagram
The following diagram shows key molecular relationships for PRKN — Parkin RBR E3 Ubiquitin Protein Ligase based on knowledge graph edges:
Pathway Diagram
The following diagram shows the key molecular relationships involving PRKN — Parkin RBR E3 Ubiquitin Protein Ligase discovered through SciDEX knowledge graph analysis:
Associated Diseases
- Als — associated with
- ALS — associated with
- Alzheimer — associated with
- dementia — associated with
- Early Onset Parkinson's Disease — risk factor for
- frontotemporal — associated with
- Parkinson — associated with
- Parkinson Disease — risk factor for
- Parkinson's disease — associated with
- Parkinson's Disease — associated with
- Parkinson'S Disease — associated with
- PARKINSONS_DISEASE — associated with
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | genes-prkn |
| kg_node_id | PRKN |
| entity_type | gene |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-af57ce2d11f5 |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'genes-prkn'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-genes-prkn?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[PRKN — Parkin RBR E3 Ubiquitin Protein Ligase](http://scidex.ai/artifact/wiki-genes-prkn)
http://scidex.ai/artifact/wiki-genes-prkn